BLCM logo

Bellicum Pharmaceuticals (BLCM) Free Cash Flow

Annual FCF

-$25.80 M
-$2.69 M-11.64%

December 31, 2022

Summary

Performance

1-Year Change

-11.64%

3-Year Change

+66.96%

5-Year Change

+69.68%

15-Year Change

+69.68%

BLCM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$7.98 M

3-Year Low

-$25.80 M
BLCM annual free cash flow is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
BLCM previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
BLCM next annual earnings announcement has not yet been scheduled

OtherBLCMcash flowmetrics:

Annual CFO

-$25.78 M
BLCM annual cash flow from operations is -$25.78 million

Annual CFF

$0.00
BLCM annual cash flow from financing activities is $0.00

Annual CFI

-$21.00 K
BLCM annual cash flow from investing activities is -$21.00 thousand

Annual CAPEX

$21.00 K
BLCM annual capital expenditures is $21.00 thousand

Quarterly FCF

-$1.52 M
+$6.48 M+81.03%

September 1, 2023

Summary

Performance

3-Month Change

+81.03%

1-Year Change

+74.33%

3-Year Change

+88.67%

5-Year Change

+91.05%

BLCM Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$1.00 M

3-Year Low

-$7.99 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2023
BLCM previous earnings announcement was published on Sep 1, 2023

Next Quarterly Earnings Report Date

N/A
BLCM next earnings announcement has not yet been scheduled

OtherBLCMcash flowmetrics:

Quarterly CFO

-$1.52 M
BLCM quarterly cash flow from operations is -$1.52 million

Quarterly CFF

-
BLCM quarterly cash flow from financing activities value is unknown

Quarterly CFI

$15.00 K
BLCM quarterly cash flow from investing activities is $15.00 thousand

Quarterly CAPEX

$0.00
BLCM quarterly capital expenditures is $0.00

TTM FCF

-$22.86 M
+$4.39 M+16.11%

September 1, 2023

Summary

Performance

3-Month Change

+16.11%

1-Year Change

+8.24%

3-Year Change

+59.74%

5-Year Change

+70.73%

BLCM TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$3.24 M

3-Year Low

-$27.25 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2023
BLCM previous earnings announcement was published on Sep 1, 2023

Next Quarterly Earnings Report Date

N/A
BLCM next earnings announcement has not yet been scheduled

OtherBLCMcash flowmetrics:

TTM CFO

-$22.85 M
BLCM TTM cash flow from operations is -$22.85 million

TTM CFF

-
BLCM TTM cash flow from financing activities value is unknown

TTM CFI

$4000.00
BLCM TTM cash flow from investing activities is $4000.00

TTM CAPEX

$11.00 K
BLCM TTM capital expenditures is $11.00 thousand

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

-$25.80 M
BLCM annual free cash flow is -$25.80 million

Annual CFO

-$25.78 M
BLCM annual cash flow from operations is -$25.78 million

Annual CAPEX

$21.00 K
BLCM annual capital expenditures is $21.00 thousand

BLCM Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-11.6%+74.3%+8.2%
3 y3 years+67.0%+88.7%+59.7%
5 y5 years+69.7%+91.0%+70.7%

BLCM Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+11.6%at lowat high+427.2%+14.2%+19.2%
5 y5-year+11.6%+202.6%+51.1%+974.7%+14.2%+241.6%
alltimeall time+223.4%+229.9%+51.1%+3234.6%+605.6%+279.0%

Bellicum Pharmaceuticals Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2023
-
-$1.52 M(-81.0%)
-$22.86 M(-16.1%)
Jun 2023
-
-$7.99 M(+24.2%)
-$27.25 M(+5.4%)
Mar 2023
-
-$6.43 M(-7.0%)
-$25.86 M(+0.2%)
Dec 2022
-$25.80 M(+11.6%)
-$6.92 M(+17.2%)
-$25.80 M(+3.6%)
Sep 2022
-
-$5.91 M(-10.5%)
-$24.91 M(+24.5%)
Jun 2022
-
-$6.60 M(+3.3%)
-$20.01 M(-5.6%)
Mar 2022
-
-$6.38 M(+5.9%)
-$21.20 M(-8.3%)
Dec 2021
-$23.11 M(-59.6%)
-$6.03 M(+501.0%)
-$23.11 M(-23.7%)
Sep 2021
-
-$1.00 M(-87.1%)
-$30.28 M(-29.0%)
Jun 2021
-
-$7.79 M(-6.1%)
-$42.66 M(-13.4%)
Mar 2021
-
-$8.29 M(-37.1%)
-$49.28 M(-14.0%)
Dec 2020
-$57.27 M(-26.7%)
-$13.19 M(-1.4%)
-$57.27 M(+0.9%)
Sep 2020
-
-$13.38 M(-7.1%)
-$56.78 M(-8.7%)
Jun 2020
-
-$14.41 M(-11.6%)
-$62.19 M(-10.8%)
Mar 2020
-
-$16.29 M(+28.3%)
-$69.70 M(-10.8%)
Dec 2019
-$78.09 M(+2.2%)
-$12.70 M(-32.4%)
-$78.09 M(-9.3%)
Sep 2019
-
-$18.79 M(-14.2%)
-$86.09 M(+2.2%)
Jun 2019
-
-$21.91 M(-11.2%)
-$84.24 M(+2.7%)
Mar 2019
-
-$24.69 M(+19.3%)
-$82.00 M(+7.3%)
Dec 2018
-$76.40 M
-$20.70 M(+22.1%)
-$76.40 M(+9.0%)
DateAnnualQuarterlyTTM
Sep 2018
-
-$16.95 M(-13.8%)
-$70.11 M(-4.8%)
Jun 2018
-
-$19.67 M(+3.0%)
-$73.68 M(-8.1%)
Mar 2018
-
-$19.09 M(+32.5%)
-$80.16 M(-5.8%)
Dec 2017
-$85.12 M(+47.6%)
-$14.40 M(-29.8%)
-$85.12 M(-1.8%)
Sep 2017
-
-$20.52 M(-21.5%)
-$86.64 M(+10.0%)
Jun 2017
-
-$26.15 M(+8.8%)
-$78.74 M(+15.5%)
Mar 2017
-
-$24.05 M(+51.0%)
-$68.18 M(+18.2%)
Dec 2016
-$57.66 M(+40.1%)
-$15.92 M(+26.1%)
-$57.66 M(+5.4%)
Sep 2016
-
-$12.62 M(-19.0%)
-$54.70 M(+6.5%)
Jun 2016
-
-$15.59 M(+15.2%)
-$51.37 M(+9.9%)
Mar 2016
-
-$13.53 M(+4.4%)
-$46.72 M(+13.5%)
Dec 2015
-$41.15 M(-29.2%)
-$12.96 M(+39.5%)
-$41.15 M(-47.7%)
Sep 2015
-
-$9.29 M(-15.1%)
-$78.74 M(+11.4%)
Jun 2015
-
-$10.94 M(+37.5%)
-$70.68 M(+12.5%)
Mar 2015
-
-$7.96 M(-84.3%)
-$62.83 M(+8.1%)
Dec 2014
-$58.11 M(+628.4%)
-$50.55 M(+4020.0%)
-$58.11 M(+668.8%)
Sep 2014
-
-$1.23 M(-60.3%)
-$7.56 M(+19.4%)
Jun 2014
-
-$3.09 M(-4.6%)
-$6.33 M(+95.4%)
Mar 2014
-
-$3.24 M
-$3.24 M
Dec 2013
-$7.98 M(-18.5%)
-
-
Dec 2012
-$9.79 M
-
-

FAQ

  • What is Bellicum Pharmaceuticals annual free cash flow?
  • What is the all time high annual FCF for Bellicum Pharmaceuticals?
  • What is Bellicum Pharmaceuticals annual FCF year-on-year change?
  • What is Bellicum Pharmaceuticals quarterly free cash flow?
  • What is the all time high quarterly FCF for Bellicum Pharmaceuticals?
  • What is Bellicum Pharmaceuticals quarterly FCF year-on-year change?
  • What is Bellicum Pharmaceuticals TTM free cash flow?
  • What is the all time high TTM FCF for Bellicum Pharmaceuticals?
  • What is Bellicum Pharmaceuticals TTM FCF year-on-year change?

What is Bellicum Pharmaceuticals annual free cash flow?

The current annual FCF of BLCM is -$25.80 M

What is the all time high annual FCF for Bellicum Pharmaceuticals?

Bellicum Pharmaceuticals all-time high annual free cash flow is -$7.98 M

What is Bellicum Pharmaceuticals annual FCF year-on-year change?

Over the past year, BLCM annual free cash flow has changed by -$2.69 M (-11.64%)

What is Bellicum Pharmaceuticals quarterly free cash flow?

The current quarterly FCF of BLCM is -$1.52 M

What is the all time high quarterly FCF for Bellicum Pharmaceuticals?

Bellicum Pharmaceuticals all-time high quarterly free cash flow is -$1.00 M

What is Bellicum Pharmaceuticals quarterly FCF year-on-year change?

Over the past year, BLCM quarterly free cash flow has changed by +$4.39 M (+74.33%)

What is Bellicum Pharmaceuticals TTM free cash flow?

The current TTM FCF of BLCM is -$22.86 M

What is the all time high TTM FCF for Bellicum Pharmaceuticals?

Bellicum Pharmaceuticals all-time high TTM free cash flow is -$3.24 M

What is Bellicum Pharmaceuticals TTM FCF year-on-year change?

Over the past year, BLCM TTM free cash flow has changed by +$2.05 M (+8.24%)